全球兒科灌注市場按產品類型、應用、最終用戶和地區分類

Global Pediatric Perfusion Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球兒科灌注市場規模估計為 5.753 億美元，預計到 2032 年將達到 8.425 億美元，2025 年至 2032 年的複合年成長率為 5.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	5.753億美元
效能數據	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	5.60%	2032年價值預測	8.425億美元

數字。 2025年全球市場佔有率（按地區）

兒科灌注是指在開胸心臟外科手術期間透過接受心肺體外迴圈(CPB) 的兒童的循環系統泵送血液。 CPB 涉及透過心肺機轉移患者的血液循環，以維持血液循環和肺部氣體交換，同時心臟停止跳動以進行手術修復的某些部分。兒科灌注需要專門的設備、技術和技能來適應成人和兒科患者之間的解剖和生理差異。在過去的幾十年裡，灌注技術的進步、電路設計的改進以及兒科手術技術的創新顯著提高了手術的成功率。然而，先天性心臟疾病仍然是全球嬰兒死亡的主要原因之一。

市場動態：

世界衛生組織 (WHO) 估計，先天性心臟疾病(CHD) 影響近 1% 的新生兒。診斷技術的進步使得能夠早期發現先天性心臟病，再加上兒科心臟外科手術的進步，提高了存活率和治療效果。因此，受益於小兒心血管手術和小兒灌注服務的兒童數量正在增加。

兒科灌注使用心肺機在心血管手術期間為兒童提供心肺支持。隨著越來越多的新生兒和嬰兒被診斷出患有先天性心臟病並接受矯正和姑息手術，對專門灌注設備的需求正在增加。外科手術的進步使得人們能夠更早進行複雜的心血管手術，從而提高先天性心臟病兒童的壽命和生活品質。

然而，兒科灌注市場也面臨挑戰。小兒心血管手術的高昂費用會給醫療保健系統和家庭帶來沉重的經濟負擔，尤其是在缺乏全面醫療保險覆蓋的地區。此外，兒科灌注需要特殊的專業知識，並且缺乏訓練有素的兒科灌注師。另一個挑戰是人們越來越關注非體外循環手術，這可能會限制灌注裝置的市場。由於這些手術無需停止心臟即可進行，因此不需要心肺機，從而有可能減少對灌注服務的需求。

儘管有這些挑戰，兒科灌注市場仍存在著巨大的機會，特別是在微型灌注設備的創新和開發方面。這些設備更適合新生兒和嬰兒的生理需要，提供更精確的控制和更少的併發症。這是兒科心臟護理領域的重大進步，為市場參與者提供了極具吸引力的機會。新興市場的醫療保健基礎設施正在不斷擴大，兒科心臟護理服務也正在改善，因此也具有成長潛力。這些地區對醫療保健服務的需求激增，這可能會推動市場擴張。

摘要：隨著醫學的不斷進步，如果能夠從策略上解決成本、培訓和技術挑戰，全球兒科灌注市場將有望實現成長。製造商和醫療保健提供者可以透過投資專為兒科護理設計的專業、經濟高效且技術先進的灌注系統來利用這些機會。

本研究的主要特點

本報告對全球兒科灌注市場進行了詳細分析，並給出了預測期（2025-2032 年，以 2024 年為基準年）的市場規模和年複合成長率（CAGR%）。
它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，介紹了全球兒科灌注市場的主要企業概況。
本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球兒科灌注市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
可以透過用於分析全球兒科灌注市場的各種策略矩陣來促進相關人員的決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 575.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 842.5 Mn

Pediatric perfusion is the delivery of blood through the circulatory system in children undergoing cardiopulmonary bypass (CPB) during open heart surgery. CPB involves diverting the patient's blood circulation through a heart-lung machine to maintain circulation and lung gas exchange while the heart is stopped during specific parts of the surgical repair. Pediatric perfusion requires specialized equipment, techniques, and skills to handle the anatomical and physiological differences between adult and pediatric patients. Over the past few decades, procedural success rates have significantly improved due to advancements in perfusion technologies, circuit design modifications, and innovations in surgical techniques tailored for children. However, congenital heart defects continue to be one of the major causes of infant mortality worldwide.

Market Dynamics:

The global pediatric perfusion market is experiencing growth primarily due to the increasing incidence of congenital heart diseases (CHD), a condition affecting nearly 1% of live births according to World Helath Organization (WHO) estimates. Improved diagnostic techniques have led to the early identification of CHD, which, coupled with advancements in pediatric cardiac surgical procedures, has improved survival rates and outcomes. Consequently, this has elevated the number of children who can benefit from pediatric cardiac surgeries and, by extension, pediatric perfusion services.

Pediatric perfusion involves the use of a heart-lung machine to support the child's cardiopulmonary functions during cardiac surgery. As more newborns and infants are diagnosed with CHD and undergo corrective or palliative surgeries, the demand for specialized perfusion equipment has grown. The surgical advancements have allowed for complex cardiac interventions to be performed at earlier stages of life, extending the longevity and quality of life of pediatric CHD patients.

However, the pediatric perfusion market does face challenges. The high cost of pediatric cardiac surgeries can be a significant financial burden for healthcare systems and families, particularly in regions without comprehensive health insurance coverage. Moreover, pediatric perfusion requires specific expertise, and there is a recognized gap in the availability of trained pediatric perfusionists. Another challenge is the increasing focus on off-pump surgical procedures, which can limit the market for perfusion equipment. These surgeries, performed without stopping the heart, may not require a heart-lung machine, thereby decreasing the demand for perfusion services.

Despite these challenges, there are substantial opportunities in the pediatric perfusion market, particularly in the innovation and development of miniaturized perfusion equipment. These devices are better suited for the physiological needs of neonates and infants, offering more precise control and reduced complications. This represents a significant advancement in pediatric cardiac care, offering an attractive opportunity for players in the market. There is also potential for growth in emerging markets, where healthcare infrastructure is expanding, and access to pediatric cardiac care is improving. The burgeoning demand for healthcare services in these regions can stimulate market expansion.

In summary, as medical advancements continue, the global pediatric perfusion market is well-positioned for growth, provided that challenges around costs, training, and technology are strategically addressed. Manufacturers and healthcare providers can capitalize on these opportunities by investing in specialized, cost-effective, and technologically advanced perfusion systems designed for pediatric care.

Key Features of the Study:

This report provides an in-depth analysis of the global pediatric perfusion market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pediatric perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, GE Healthcare, LivaNova, PLC., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pediatric perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric perfusion market

Detailed Segmentation:

By Product Type:
- Pediatric Cannulas
- Centrifugal Blood Pumps
- Pediatric Arterial Lines
- Membrane Oxygenators
- Extracorporeal Circuits
- Others
By Application
- Cardiovascular Surgery
- Respiratory Applications
- Extracorporeal Membrane Oxygenation
- Cardiopulmonary Bypass
- Organ Perfusion and Preservation
- Organ Transplantation
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Medtronic
- GE Healthcare
- LivaNova, PLC.
- Getinge
- Braile Biomedica
- XENIOS AG
- BL Lifesciences
- Terumo Corporation
- 3M
- Koninklijke Philips N.V.
- EUROSETS
- Merck KGaA
- Stryker
- Cardinal Health
- Nonin
- Sorin Group USA, Inc.\

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Pediatric Perfusion Market, By Product Type
- Pediatric Perfusion Market, By Application
- Pediatric Perfusion Market, By End User
- Pediatric Perfusion Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- The increasing incidence of cardiovascular diseases (CVDs) in the pediatric population
- Increasing government initiatives and funding
- The emergence of new technologies in pediatric perfusion
- Technological advancements
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pediatric Perfusion Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pediatric Perfusion Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Cannulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Centrifugal Blood Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pediatric Arterial Lines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Membrane Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Extracorporeal Circuits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Pediatric Perfusion Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Respiratory Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Extracorporeal Membrane Oxygenation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiopulmonary Bypass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Organ Perfusion and Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Organ Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Pediatric Perfusion Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Pediatric Perfusion Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medtronic
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
LivaNova, PLC.
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Getinge
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braile Biomedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
XENIOS AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BL Lifesciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
EUROSETS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cardinal Health
Nonin
Sorin Group USA, Inc.
Analyst Views